Traws Pharma, Inc. (TRAW)

Traws Pharma Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	11	16	14	53	86	3
Market Cap Growth	38.45%	15.90%	-74.64%	-38.16%	2643.92%	-73.78%
Enterprise Value	-5	-5	-25	-2	67	-20
PE Ratio	-	-0.83	-0.71	-3.30	-3.42	-0.15
PS Ratio	48.33	69.29	59.79	235.71	372.94	1.44
PB Ratio	1.82	1.47	0.48	1.16	13.95	0.27
P/FCF Ratio	-1.19	-0.87	-0.83	-2.73	-3.73	-0.15
P/OCF Ratio	-1.19	-0.87	-0.83	-2.73	-3.73	-0.15
EV/Sales Ratio	21.34	-22.84	-111.70	-7.96	290.58	-8.97
EV/EBITDA Ratio	-0.27	0.27	1.33	0.11	-2.67	0.91
EV/EBIT Ratio	-0.27	0.27	1.33	0.11	-2.67	0.91
EV/FCF Ratio	-0.27	0.29	1.55	0.09	-2.91	0.94
Quick Ratio	1.74	2.26	4.82	9.01	1.90	2.75
Current Ratio	1.93	2.46	4.89	9.07	1.97	2.83
Asset Turnover	0.01	0.01	0.01	0.00	0.01	0.18
Return on Equity (ROE)	-145.00%	-113.20%	-53.30%	-39.00%	-181.70%	15667.00%
Return on Assets (ROA)	-73.80%	-65.80%	-41.50%	-31.00%	-95.40%	-173.40%
Return on Capital (ROIC)	-322.08%	-190.20%	-69.33%	-35.77%	-404.74%	-187.48%
Earnings Yield	-166.23%	-121.00%	-140.35%	-30.34%	-29.20%	-684.89%
FCF Yield	-163.09%	-114.60%	-120.59%	-36.58%	-26.80%	-665.24%
Buyback Yield / Dilution	-0.40%	-0.39%	-24.22%	-45.08%	-1109.89%	-248.79%
Total Shareholder Return	-0.40%	-0.39%	-24.22%	-45.08%	-1109.89%	-248.79%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).